Cheshire, UK--(Marketwire - January 22, 2008) -
Protherics PLC
Notification of Major Interests in Shares
London, UK; Brentwood, TN, US: 22 January 2008 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, announces that, on 21 January 2008, in accordance with the
Transparency Obligations Directive, a notification of interest in the ordinary
share capital of the Company was received from AXA Investment Managers UK
Limited on behalf of AXA S.A. and its Group Companies ("AXA"). Details of the
notification are as follows:
1. Reason for the notification (please tick the appropriate box or boxes)
A disposal of voting rights X
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):
2. Full name of person(s) subject to the AXA S.A., 25 Avenue Matignon, 75008 Paris and its
notification obligation: group of companies.
3. Full name of shareholder(s) (if different
from 2.):
4. Date of the transaction (and date on which 17 January 2008
the threshold is crossed or reached if
different):
5. Date on which issuer notified: 18 January 2008
6. Threshold(s) that is/are crossed or reached: 13%
7. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after the triggering transaction
shares the Triggering
transaction
if possible using Number of Number of Number of Number of voting rights % of voting rights
the ISIN CODE Shares Voting shares
Rights Direct Direct Indirect Direct Indirect
0702920 49,639,830 49,639,830 741,666 741,666 43,053,507 0.22% 12.66%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ Conversion Number of voting rights % of voting rights
instrument Period/ Date that may be acquired if
the instrument is
exercised/ converted.
Total (A+B)
Number of voting rights % of voting rights
43,795,173 12.87%
8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are
effectively held, if applicable :
Name of Company/Fund Number of Shares % of issued share capital
AXA UK Investment Co ICVC 546,090 0.16052
UK Smaller Companies Fund
Indirect
Sun Life Pensions Management Ltd 25,000 0.00735
Direct
Sun Life Unit Assurance Ltd 53,913 0.01585
FTSE All Share Tracker Life
Direct
Sun Life Pensions Management 294,874 0.08668
FTSE All Share Tracker Pension
Direct
AXA Framlington 750,000 0.22046
SEI UK Equity
Indirect
AXA Framlington 1,600,000 0.47031
St James Place Exempt (Pens) Fund
Indirect
AXA Framlington 1,800,000 0.52910
St James Place Net (Life) Fund
Indirect
AXA Framlington 400,000 0.11758
St James Place Offshore Fund
Indirect
AXA Framlington 600,000 0.17637
Daimler Chrysler
Indirect
AXA Framlington 3,120,333 0.91720
Throgmorton Trust
Indirect
AXA Framlington 15,013,453 4.41308
UK Selet Ops
Indirect
AXA Framlington 13,753,131 4.04262
Equity Income
Indirect
AXA Framlington 2,000,000 0.58788
Managed Balanced
Indirect
AXA Framlington 1,500,000 0.44091
UK Smaller Companies
Indirect
AXA Framlington 500,000 0.14697
BAE Systems Pensions Fund CIF Trustees
Indirect
AXA Framlington 220,000 0.06467
BAE Systems 2000 Pensions Fund
Indirect
Framlington onshore private clients 975,500 0.28674
Indirect
Axa Sun Life With Profits Passive 226,817 0.06667
Direct
Axa Sun Life With Profits Passive 141,062 0.04146
Direct
AXA Framlington 275,000 0.08083
St James Place Internal Equity & Income UT
Indirect
Total Direct 741,666 0.21801
Total Indirect 43,053,507 12.65523
TOTAL 43,795,173 12.87324
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting
rights:
12. Additional information:
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange